Corbus Pharmaceuticals Holdings IncNASDAQ:CRBP
- LAST PRICE44.2100
- TODAY'S CHANGE (%)-5.8900 (-11.7565%)
- Bid / Lots44.2100/ 1
- Ask / Lots44.5000/ 2
- Open / Previous Close48.3100 / 50.1000
- Day Range
- 52 Week Range
- Volume329,739
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRBP |
|---|---|---|
| 09:32 ET | 4972 | 49.3226 |
| 09:34 ET | 100 | 48.26 |
| 09:36 ET | 436 | 48.97 |
| 09:38 ET | 1052 | 48.62 |
| 09:39 ET | 100 | 48.88 |
| 09:41 ET | 1072 | 48.51 |
| 09:43 ET | 400 | 48.455 |
| 09:45 ET | 100 | 48.55 |
| 09:48 ET | 2698 | 48.49 |
| 09:50 ET | 2297 | 47.78 |
| 09:52 ET | 800 | 47.78 |
| 09:54 ET | 200 | 47.66 |
| 09:56 ET | 2748 | 47.78 |
| 09:57 ET | 500 | 47.725 |
| 09:59 ET | 882 | 47.965 |
| 10:01 ET | 100 | 48.05 |
| 10:06 ET | 200 | 48.055 |
| 10:10 ET | 104 | 48.07 |
| 10:14 ET | 200 | 48.4 |
| 10:19 ET | 3895 | 47.635 |
| 10:21 ET | 476 | 47.325 |
| 10:24 ET | 1349 | 47.5 |
| 10:26 ET | 600 | 47.39 |
| 10:28 ET | 276 | 47.57 |
| 10:30 ET | 200 | 47.59 |
| 10:33 ET | 200 | 47.5 |
| 10:39 ET | 300 | 47.6 |
| 10:42 ET | 376 | 47.65 |
| 10:44 ET | 1000 | 47.315 |
| 10:46 ET | 400 | 47.22 |
| 10:48 ET | 3250 | 47.49 |
| 10:50 ET | 3711 | 47.25 |
| 10:51 ET | 5103 | 47.37 |
| 10:53 ET | 1165 | 47.22 |
| 10:55 ET | 4032 | 46.8 |
| 10:57 ET | 400 | 46.75 |
| 11:00 ET | 900 | 47.32 |
| 11:04 ET | 100 | 47.17 |
| 11:06 ET | 200 | 47.135 |
| 11:09 ET | 200 | 47.32 |
| 11:15 ET | 238 | 46.87 |
| 11:18 ET | 2425 | 47.13 |
| 11:20 ET | 601 | 46.965 |
| 11:22 ET | 200 | 46.815 |
| 11:24 ET | 700 | 46.95 |
| 11:27 ET | 200 | 46.95 |
| 11:29 ET | 500 | 46.875 |
| 11:31 ET | 100 | 46.905 |
| 11:33 ET | 100 | 46.86 |
| 11:36 ET | 700 | 46.7125 |
| 11:38 ET | 260 | 46.89 |
| 11:40 ET | 400 | 46.47 |
| 11:42 ET | 400 | 46.6 |
| 11:44 ET | 200 | 46.605 |
| 11:45 ET | 200 | 46.39 |
| 11:47 ET | 400 | 46.45 |
| 11:51 ET | 100 | 46.305 |
| 11:56 ET | 800 | 46.4 |
| 11:58 ET | 600 | 46.4 |
| 12:02 ET | 200 | 46.51 |
| 12:03 ET | 1400 | 46.96 |
| 12:05 ET | 200 | 46.92 |
| 12:07 ET | 305 | 46.7476 |
| 12:09 ET | 100 | 46.84 |
| 12:12 ET | 700 | 46.81 |
| 12:14 ET | 200 | 46.775 |
| 12:16 ET | 100 | 46.91 |
| 12:18 ET | 200 | 46.94 |
| 12:20 ET | 100 | 46.725 |
| 12:21 ET | 100 | 46.93 |
| 12:23 ET | 100 | 46.77 |
| 12:25 ET | 2000 | 46.7 |
| 12:27 ET | 2500 | 46.61 |
| 12:30 ET | 335 | 46.46 |
| 12:32 ET | 3186 | 46.35 |
| 12:34 ET | 200 | 46.32 |
| 12:38 ET | 4400 | 46.18 |
| 12:39 ET | 100 | 46.175 |
| 12:41 ET | 500 | 46.07 |
| 12:43 ET | 800 | 46.19 |
| 12:45 ET | 400 | 46.37 |
| 12:50 ET | 2286 | 46.3 |
| 12:52 ET | 968 | 46.22 |
| 12:54 ET | 300 | 46.05 |
| 12:56 ET | 800 | 46.05 |
| 12:57 ET | 668 | 46.05 |
| 01:01 ET | 1920 | 45.7 |
| 01:03 ET | 2889 | 45.37 |
| 01:06 ET | 200 | 45.385 |
| 01:08 ET | 300 | 45.33 |
| 01:10 ET | 215 | 45.38 |
| 01:12 ET | 500 | 45.33 |
| 01:14 ET | 100 | 45.18 |
| 01:15 ET | 200 | 45.2 |
| 01:17 ET | 1376 | 45.46 |
| 01:19 ET | 698 | 45.5 |
| 01:24 ET | 600 | 45.6132 |
| 01:26 ET | 200 | 45.36 |
| 01:28 ET | 100 | 45.5899 |
| 01:30 ET | 3040 | 45.15 |
| 01:32 ET | 3041 | 45.14 |
| 01:33 ET | 658 | 44.96 |
| 01:35 ET | 100 | 44.9565 |
| 01:37 ET | 800 | 44.99 |
| 01:39 ET | 256 | 44.89 |
| 01:42 ET | 900 | 45 |
| 01:44 ET | 400 | 44.97 |
| 01:46 ET | 100 | 45.075 |
| 01:48 ET | 200 | 45.0717 |
| 01:50 ET | 323 | 45.135 |
| 01:51 ET | 1300 | 45.105 |
| 01:53 ET | 1100 | 45.26 |
| 01:55 ET | 850 | 45.22 |
| 02:00 ET | 500 | 45.32 |
| 02:02 ET | 300 | 45.6 |
| 02:04 ET | 400 | 45.53 |
| 02:06 ET | 100 | 45.73 |
| 02:08 ET | 1130 | 45.25 |
| 02:09 ET | 929 | 45.78 |
| 02:13 ET | 500 | 45.86 |
| 02:15 ET | 100 | 45.715 |
| 02:20 ET | 350 | 45.5524 |
| 02:22 ET | 500 | 45.56 |
| 02:24 ET | 800 | 45.385 |
| 02:26 ET | 100 | 45.32 |
| 02:27 ET | 100 | 45.245 |
| 02:31 ET | 200 | 45.23 |
| 02:33 ET | 700 | 45.335 |
| 02:36 ET | 450 | 45.4923 |
| 02:42 ET | 100 | 45.42 |
| 02:44 ET | 500 | 45.56 |
| 02:45 ET | 2836 | 45.4 |
| 02:47 ET | 1380 | 45.2801 |
| 02:49 ET | 200 | 45.5601 |
| 02:51 ET | 302 | 45.64 |
| 02:54 ET | 200 | 45.59 |
| 02:56 ET | 900 | 45.64 |
| 02:58 ET | 400 | 45.74 |
| 03:00 ET | 949 | 45.62 |
| 03:02 ET | 100 | 45.625 |
| 03:03 ET | 800 | 45.56 |
| 03:05 ET | 600 | 45.56 |
| 03:07 ET | 100 | 45.56 |
| 03:09 ET | 340 | 45.6 |
| 03:12 ET | 1891 | 45.725 |
| 03:16 ET | 100 | 45.84 |
| 03:18 ET | 600 | 45.84 |
| 03:20 ET | 2524 | 45.54 |
| 03:21 ET | 100 | 45.53 |
| 03:23 ET | 5540 | 45.35 |
| 03:25 ET | 298 | 45.31 |
| 03:27 ET | 10766 | 44.82 |
| 03:30 ET | 3165 | 44.5 |
| 03:32 ET | 975 | 44.21 |
| 03:34 ET | 300 | 44.29 |
| 03:36 ET | 3049 | 44.02 |
| 03:38 ET | 1791 | 44.03 |
| 03:39 ET | 2035 | 44.0451 |
| 03:41 ET | 800 | 44.05 |
| 03:43 ET | 2924 | 44.002 |
| 03:45 ET | 1578 | 44.11 |
| 03:48 ET | 2659 | 44.1399 |
| 03:50 ET | 3177 | 44.05 |
| 03:52 ET | 1243 | 44.05 |
| 03:54 ET | 17127 | 43.845 |
| 03:56 ET | 3098 | 43.87 |
| 03:57 ET | 21204 | 44.23 |
| 03:59 ET | 17629 | 44.21 |
Jun 11, 2024
DJ Corbus Pharmaceuticals Is Maintained at Outperform by RBC Capital, from 8:27AM ET on Tuesday Jun 11, 2024 by Dow Jones
8:27AM ET on Tuesday Jun 11, 2024 by Dow Jones
Jun 3, 2024
DJ Corbus Pharmaceuticals Reaches 2-Year High After Drug Results, from 1:11PM ET on Monday Jun 03, 2024 by Dow Jones
1:11PM ET on Monday Jun 03, 2024 by Dow JonesDJ Corbus Pharmaceuticals Is Maintained at Outperform by Oppenheimer, from 8:33AM ET on Monday Jun 03, 2024 by Dow Jones
8:33AM ET on Monday Jun 03, 2024 by Dow Jones
Jun 1, 2024
SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024, from 10:00AM ET on Saturday Jun 01, 2024 by Dow Jones
10:00AM ET on Saturday Jun 01, 2024 by Dow Jones
May 30, 2024
Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference, from 8:00AM ET on Thursday May 30, 2024 by Dow Jones
8:00AM ET on Thursday May 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Corbus Pharmaceuticals Holdings Inc | 535.4M | -6.3x | --- |
Terns Pharmaceuticals Inc | 530.4M | -6.3x | --- |
Celcuity Inc | 527.6M | -5.2x | --- |
Third Harmonic Bio Inc | 545.9M | -17.3x | --- |
Neurogene Inc | 552.8M | -8.7x | --- |
Erasca Inc | 516.4M | -2.4x | --- |
Company Information
Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.
Contact Information
- Headquarters
- 500 River Ridge DriveNORWOOD, MA, United States 02062
- Phone
- 617-963-0103
- Fax
- ---
Executives
- Independent Chairman of the Board
- Alan Holmer
- Chief Executive Officer, Director
- Yuval Cohen
- Chief Financial Officer
- Sean Moran
- Chief Medical Officer
- Dominic Smethurst
- Independent Director
- Anne Altmeyer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $535.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 10.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.61 |
EPS | $-6.97 |
Book Value | $-1.56 |
P/E Ratio | -6.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
